Canary Capital Submits S-1 Filing For Staked Injective ETF

Canary Capital Staked INJ ETF entered focus after the firm filed an amended S-1 with the U.S. Securities and Exchange Commission, offering clearer details on how the proposed fund would track Injective and earn staking rewards under a regulated setup.

Canary Capital Staked INJ ETF Filing Explains Fund Setup

Canary Capital submitted its first amendment to the S-1 registration for its Staked INJ ETF, according to a recent SEC filing. 

The update explains how the fund plans to give investors direct exposure to the spot price of Injective while also earning extra INJ through staking. If the filing gains approval, the ETF is expected to list on the Cboe exchange.

The prospectus names U.S. Bancorp Fund Services as the transfer agent and cash custodian for the trust. BitGo Trust Company will act as the digital asset custodian, holding all INJ tokens owned by the fund. The filing did not name a specific staking provider, but Canary Capital said the trust will stake all INJ through one or more providers.

The ETF will track Injective price movements using the INJ-USD CCIXber Reference Rate. Shares will be issued and redeemed in blocks of 10,000, which follows common ETF practice. Paralel Distributors LLC is listed as the marketing agent. Details such as the ticker symbol and management fee were not included and may appear in later filings.

Staking Plan Sets Canary Capital Staked INJ ETF Apart

The filing shows that Canary Capital wants the ETF to combine price tracking with staking income. By staking the INJ held by the trust, the fund aims to reflect both market price changes and staking rewards in its net value, after costs.

This setup could attract investors who want exposure to Injective without dealing with private keys, validators, or staking tools. It also shows how issuers are testing new ways to structure crypto ETFs beyond simple price tracking. Still, the ETF remains under review, and approval is not guaranteed.

In related news, Canary Capital recently filed with the U.S. SEC to launch an ETF tracking Mog Coin, a memecoin inspired by the internet “Mog” meme.

Injective Price Weakness Continues

It is worth mentioning that the Injective price continued to trade under pressure as the broader crypto market remained weak. 

INJ fell more than 4% over the past 24 hours, trading around $4.58. The price ranged between an intraday low of $4.54 and a high of $5.08, while trading volume rose by about 5%.

On the daily chart, INJ remains below its 50-day, 100-day, and 200-day moving averages. The Relative Strength Index dropped to 30.67, a level often watched by traders for possible short-term rebounds. Some analysts pointed to the $4.50 area as a potential entry level, with $5.50 seen as a key level to reclaim.